Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal betamethasone to prevent respiratory distress syndrome in late preterm neonates (35–36 weeks)
IRCT138901193666N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of betamethasone in respiratory distress syndrome (RDS), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Incidence of neonatal respiratory distress syndrome. Started Jan 2006; status: completed.
02
Drugs
betamethasone
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT138901193666N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138901193666N1.